Cleanroom Airborne Particulate Limits and 70% Isopropyl Alcohol: A Lingering Problem for Pharmaceutical Manufacturing?

References

1. ↵
   Annex 1, Manufacture of Sterile Medicinal Products, European Union GMPs; European Commission, 2003.
2. ↵
   Guidance for Industry. Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice; US Food and Drug Administration, 2004.
3. ↵
   Particle Measuring Systems (PMS) Inc., Application Note No. 15, Particle loss in transport tubing, 1997.
4. ↵
   1. Hinds W.

   Aerosol Technology; John Wiley and Sons: New York, 1999; pp 278– 304.
5. ↵
   1. Whyte W.

   Cleanroom Technology, Fundamentals of Design, Testing and Operation; John Wiley and Sons: Chichester, UK, 2001; p 56.
6. ↵
   EN ISO 146441. Cleanrooms and Associated Controlled Environments Part 1: Classification of air cleanliness. Geneva, International Organization for Standardization, ISO, 1999.
7. ↵
   1. Veysey S.

   Best Practice for Continuous Particle Monitoring to EU GMP Annex 1. The Pharmaceutical and Healthcare Sciences Society, Autumn Conference. Nottingham, England. October, 2008.
8. ↵
   1. Hargreaves P.

   Revised EU GMP Annex 1. Parenteral Drug Association, Manufacture of Sterile Medicinal Products EU/PICS revised GMP Annex 1, Workshop. Geneva. November, 2008.
9. ↵
   1. Eaton T.

   Annex 1 of the EC Guide to Good Manufacturing Practice (EC GGMP) and continuous particle monitoring—help or hindrance of cleanroom manufacturing? European Journal of Parenteral and Pharmaceutical Sciences 2007, 12 ( 2), 3– 7.

   OpenUrl
10. ↵
    1. Whyte W.,
    2. Eaton T.,
    3. Farquharson G.,
    4. Ljungqvist B.,
    5. Reinmüller B.

    Letter to the Editor. European Journal of Parenteral and Pharmaceutical Sciences 2007, 12 ( 2), 47– 49.

    OpenUrl